choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

Avastin Newsletter
  • Xgeva interactions: Alcohol, medications, and other factors 13 May 2024 13:56 GMT

    … these medications together. If your doctor prescribes … interact with Xgeva: bevacizumab (Avastin) cabozantinib (Cabometyx, Cometriq … doctor before stopping Xgeva treatment. They’ll help you safely stop the drug … been enough clinical trials to determine whether …

  • NC hospitals overcharge for cancer drugs, State Health Plan report says 10 May 2024 14:28 GMT

    … largest purchaser of medical and pharmaceutical services, and … avastin/bevacizumab. They focused on State Health Plan medical … substantial discounts on certain drug purchases,” Atrium said. … behaviors, taking medication recommended by doctors, and regularly …

  • Understanding Retinopathy of Prematurity: Causes, Symptoms, and Treatments 10 May 2024 09:07 GMT

    … symptoms, diagnosis, management and treatment to keep sight-threatening complications … required form of treatment. Management and Treatment Options for Retinopathy … drugs such as bevacizumab (Avastin) or ranibizumab (Lucentis) may be used. These medications

  • NC report claims hospitals overcharging for oncology drugs 10 May 2024 08:52 GMT

    … Carolina’s largest purchaser of medical and pharmaceutical services and Folwell oversees … and avastin/bevacizumab. They focused on State Health Plan medical claims … (with) substantial discounts on certain drug purchases,” Atrium said. “Discounts under …

  • Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance 08 May 2024 11:00 GMT

    … Food and Drug Administration (FDA) through which the FDA expressed its … biosimilar to Avastin®, which is indicated for the treatment of … areas of significant unmet medical need. The Company’s … Israel, more than 25 pharmaceutical products that are supplied …

  • IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update 13 May 2024 12:00 GMT

    … U.S. Food and Drug Administration (FDA) for our seasonal COVID … nearly 30 years of pharmaceutical and biotech industry experience with a … Began Treatment in a Phase 1/2 Clinical Trial Evaluating … activities and in clinical trials; the uncertainties of and …

  • Faith and hope: helping Erik heal in fight with cancer 12 May 2024 23:24 GMT

    … .” Erik was administered a chemotherapy drug that he could take at … at times without vomiting. “The doctors weren’t sure if Erik … for all these treatments (e.g. $20,000 for Avastin was not … Erik the drug and support him through this with the treatment from …

  • The Best Healthcare Stocks to Buy 09 May 2024 20:03 GMT

    … improvements in innovative treatment options.” Investment Opportunities … and seed biotechnology business. Similar to the drug business, … IV solutions, generic pharmaceuticals, and surgical tools … . Blockbuster cancer biologics Avastin, Rituxan, and Herceptin …

  • MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights 09 May 2024 20:33 GMT

    … clinical-stage pharmaceutical company evaluating novel drug candidates to … limited benefit. While treatments targeting specific patient … combination with bevacizumab (Avastin®) in refractory metastatic … clinical trials and release of clinical trial data …

  • Kamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Call Transcript 09 May 2024 15:45 GMT

    … presentation at transplantation related medical meetings this year in … biosimilar to Avastin, which is indicated for the treatment of certain … protocol. We anticipate further FDA feedback in the second half … as our Phase 3 InnovAATe trial. As we get throughout …

Satisfied with the content?

Continue to create your account.